CCR5 and prostate cancer: RANTES (CCL5) is an important member of the CC subfamily of chemokines, which has an important role in promoting proliferation, angiogenesis, metastasis and drug resistance of prostate cancer cells via its crosslinking with chemokine (C-C motif) receptor 5 (CCR5) or CCR1.